Every morning, find a selection of analysts’ recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.
- Chewy: Gordon Haskett drops coverage on the stock.
- Coinbase Global: Oppenheimer upgrades to outperform from market perform with a target price of USD 160.
- Fair Isaac: Barclays maintains its overweight recommendation and raises the target price from USD 1234 to USD 1500.
- Humana: Nephron Research maintains its buy recommendation and reduces the target price from USD 648 to USD 400. Oppenheimer maintains its outperform rating and reduces the target price from USD 630 to USD 415. Stephens maintains its overweight rating and reduces the…
